Anti-vascular endothelial growth factor dosing frequency and visual outcomes in macular oedema following branch retinal vein occlusion
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Anti-vascular endothelial growth factor dosing frequency and visual outcomes in macular oedema following branch retinal vein occlusion ; volume:37 ; number:16 ; day:8 ; month:5 ; year:2023 ; pages:3423-3428 ; date:11.2023
Eye ; 37, Heft 16 (8.5.2023), 3423-3428, 11.2023
- Creator
-
Modi, Yasha S.
Goduni, Lediana
Moini, Hadi
Gibson, Andrea
Boucher, Nick
Lucas, Genevieve
Dhoot, Dilsher S.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41433-023-02527-7
- URN
-
urn:nbn:de:101:1-2024012409292217532663
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
16.04.2025, 9:26 PM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Modi, Yasha S.
- Goduni, Lediana
- Moini, Hadi
- Gibson, Andrea
- Boucher, Nick
- Lucas, Genevieve
- Dhoot, Dilsher S.
- SpringerLink (Online service)
Other Objects (12)
How intravitreal anti-vascular endothelial growth factor initial dosing impacts patient outcomes in diabetic macular oedema
Minimally invasive laser treatment combined with intravitreal injection of anti-vascular endothelial growth factor for diabetic macular oedema
Indirect comparisons of ranibizumab and dexamethasone in macular oedema secondary to retinal vein occlusion
Suboptimal outcomes and treatment burden of anti-vascular endothelial growth factor treatment for diabetic macular oedema in phakic patients
Anti-vascular endothelial growth factor agent reduces inflammation in macular edema with central retinal vein occlusion
Real-world effects of anti-vascular endothelial growth factor injection frequency on visual outcomes in patients with diabetic macular oedema
Predicting recurrences of macular edema due to branch retinal vein occlusion during anti-vascular endothelial growth factor therapy
Influence of macular oedema on the measurement of macular pigment optical density
Efficacy and safety of widely used treatments for macular oedema secondary to retinal vein occlusion: a systematic review
Intravitreal dexamethasone implant versus triamcinolone acetonide for macular oedema of central retinal vein occlusion: quantifying efficacy and safety
Real-World Results of Switching Treatment from Ranibizumab to Aflibercept in Macular Oedema Secondary to Branch Retinal Vein Occlusion
Real-world outcomes of intravitreal bevacizumab treat-and-extend for cystoid macular oedema secondary to central retinal vein occlusion
How intravitreal anti-vascular endothelial growth factor initial dosing impacts patient outcomes in diabetic macular oedema
Minimally invasive laser treatment combined with intravitreal injection of anti-vascular endothelial growth factor for diabetic macular oedema
Indirect comparisons of ranibizumab and dexamethasone in macular oedema secondary to retinal vein occlusion
Suboptimal outcomes and treatment burden of anti-vascular endothelial growth factor treatment for diabetic macular oedema in phakic patients
Anti-vascular endothelial growth factor agent reduces inflammation in macular edema with central retinal vein occlusion
Real-world effects of anti-vascular endothelial growth factor injection frequency on visual outcomes in patients with diabetic macular oedema
Predicting recurrences of macular edema due to branch retinal vein occlusion during anti-vascular endothelial growth factor therapy
Influence of macular oedema on the measurement of macular pigment optical density
Efficacy and safety of widely used treatments for macular oedema secondary to retinal vein occlusion: a systematic review
Intravitreal dexamethasone implant versus triamcinolone acetonide for macular oedema of central retinal vein occlusion: quantifying efficacy and safety
Real-World Results of Switching Treatment from Ranibizumab to Aflibercept in Macular Oedema Secondary to Branch Retinal Vein Occlusion
Real-world outcomes of intravitreal bevacizumab treat-and-extend for cystoid macular oedema secondary to central retinal vein occlusion
How intravitreal anti-vascular endothelial growth factor initial dosing impacts patient outcomes in diabetic macular oedema
Minimally invasive laser treatment combined with intravitreal injection of anti-vascular endothelial growth factor for diabetic macular oedema
Indirect comparisons of ranibizumab and dexamethasone in macular oedema secondary to retinal vein occlusion
Suboptimal outcomes and treatment burden of anti-vascular endothelial growth factor treatment for diabetic macular oedema in phakic patients
Anti-vascular endothelial growth factor agent reduces inflammation in macular edema with central retinal vein occlusion
Real-world effects of anti-vascular endothelial growth factor injection frequency on visual outcomes in patients with diabetic macular oedema
Predicting recurrences of macular edema due to branch retinal vein occlusion during anti-vascular endothelial growth factor therapy
Influence of macular oedema on the measurement of macular pigment optical density
Efficacy and safety of widely used treatments for macular oedema secondary to retinal vein occlusion: a systematic review
Intravitreal dexamethasone implant versus triamcinolone acetonide for macular oedema of central retinal vein occlusion: quantifying efficacy and safety
Real-World Results of Switching Treatment from Ranibizumab to Aflibercept in Macular Oedema Secondary to Branch Retinal Vein Occlusion